Outcomes (% Cases) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Concordant treatment | Discordant treatment | ||||||||
Sample age groups | Antibiotic | % cases receiving antibiotic | % cases treated discordantly | % simple cure | % delayed cure | % delayed cure and hospitalized | % simple cure | % delayed cure | % delayed cure and hospitalized |
Pediatric (0- < 5 yrs) | Amoxicillin (High dose) | 9% | 37% | 71% | 24% | 5% | 69% | 23% | 8% |
Amoxicillin (Low dose) | 7% | 37% | 71% | 24% | 5% | 68% | 23% | 9% | |
Augmentin | 11% | 37% | 71% | 24% | 5% | 69% | 23% | 8% | |
Azithromycin | 28% | 32% | 71% | 24% | 5% | 45% | 15% | 40% | |
Oral Cephalosporin (2nd generation) | 7% | 8% | 71% | 24% | 5% | 68% | 22% | 10% | |
Oral Cephalosporin (3rd generation) | 24% | 8% | 71% | 24% | 5% | 68% | 22% | 10% | |
IM Ceftriaxone | 14% | 8% | 71% | 24% | 5% | 68% | 23% | 10% | |
Adult (50- < 65 yrs) | Amoxicillin | 2% | 37% | 81% | 14% | 5% | 77% | 14% | 9% |
Augmentin | 19% | 37% | 81% | 14% | 5% | 77% | 14% | 9% | |
Azithromycin | 15% | 29% | 81% | 14% | 5% | 51% | 9% | 40% | |
Oral Cephalosporin (3rd generation) | 9% | 6% | 81% | 14% | 5% | 77% | 14% | 10% | |
IM Ceftriaxone | 5% | 6% | 81% | 14% | 5% | 77% | 14% | 10% | |
Fluoroquinolones | 56% | 1% | 81% | 14% | 5% | 51% | 9% | 40% |